"Results of phase 2 trial of eritoram, a synthetic TLR-4 antagonist, in patients with severe sepsis" by Mark Tidswell, MD

Follow Contact

Article

Results of phase 2 trial of eritoram, a synthetic TLR-4 antagonist, in patients with severe sepsis

All Scholarly Works

Document Type

Presentations, Research

Publication Date

2-1-2007

Citation Information

Society of Critical Care Medicine 36th Critical Care Congress 2007 Feb. Crit Care Med 2006;34:7.